Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled amikacin for prevention of ventilator-associated pneumonia in mechanically ventilated ICU patients without baseline respiratory infection
MOH_2025-11-04_015431Phase 3Not yet recruiting
- Sponsor
- ד"ר יעקב דסקל
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ventilator-associated pneumonia (VAP) comparing Inhaled amikacin with Placebo inhaled saline (2 arms). Planned start Sep 2025; status: not yet recruiting.
02
Drugs
amikacin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on MOH_2025-11-04_015431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2025-11-04_015431.